202 related articles for article (PubMed ID: 15221424)
21. Cannabinoids, immune system and cytokine network.
Massi P; Vaccani A; Parolaro D
Curr Pharm Des; 2006; 12(24):3135-46. PubMed ID: 16918439
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
Ashton CH; Moore PB; Gallagher P; Young AH
J Psychopharmacol; 2005 May; 19(3):293-300. PubMed ID: 15888515
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Croxford JL; Yamamura T
J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
[TBL] [Abstract][Full Text] [Related]
24. Endogenous cannabinoid system as a modulator of food intake.
Cota D; Marsicano G; Lutz B; Vicennati V; Stalla GK; Pasquali R; Pagotto U
Int J Obes Relat Metab Disord; 2003 Mar; 27(3):289-301. PubMed ID: 12629555
[TBL] [Abstract][Full Text] [Related]
25. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
27. Differential role of cannabinoids in the pathogenesis of skin cancer.
Glodde N; Jakobs M; Bald T; Tüting T; Gaffal E
Life Sci; 2015 Oct; 138():35-40. PubMed ID: 25921771
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
Mechoulam R; Hanu L
Pain Res Manag; 2001; 6(2):67-73. PubMed ID: 11854768
[TBL] [Abstract][Full Text] [Related]
29. Effects of Cannabinoids on T-cell Function and Resistance to Infection.
Eisenstein TK; Meissler JJ
J Neuroimmune Pharmacol; 2015 Jun; 10(2):204-16. PubMed ID: 25876735
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
32. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids and cancer: causation, remediation, and palliation.
Hall W; Christie M; Currow D
Lancet Oncol; 2005 Jan; 6(1):35-42. PubMed ID: 15629274
[TBL] [Abstract][Full Text] [Related]
34. Marijuana, immunity and infection.
Klein TW; Friedman H; Specter S
J Neuroimmunol; 1998 Mar; 83(1-2):102-15. PubMed ID: 9610678
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL; Ineck JR
Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
[TBL] [Abstract][Full Text] [Related]
36. Immune system: a possible nexus between cannabinoids and psychosis.
Suárez-Pinilla P; López-Gil J; Crespo-Facorro B
Brain Behav Immun; 2014 Aug; 40():269-82. PubMed ID: 24509089
[TBL] [Abstract][Full Text] [Related]
37. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
[TBL] [Abstract][Full Text] [Related]
38. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
39. The role of CB1 in immune modulation by cannabinoids.
Kaplan BL
Pharmacol Ther; 2013 Mar; 137(3):365-74. PubMed ID: 23261520
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G; Goldberg SR
Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
